Cellerant Therapeutics Information
Contact top employees from
Cellerant Therapeutics
Summary
Cellerant Therapeutics is a private company that has been in the industry for 22 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the President & CEO is occupied by Ram Mandalam. Its headquarters is located at Newark, California, USA. The number of employees ranges from 25 to 100. The annual revenue of Cellerant Therapeutics varies between 5.0M and 25M. Total funding of the company - $153.9M. To connect with Cellerant Therapeutics employee register on SignalHire.
Industries
Biotechnology
Employees Size
100-200 employees
Specialties
Stem Cells, Neutropenia, Oncology, Thrombocytopenia
SIC Code
2836, 2834
DMA Code
San Francisco Bay Area
Founded
2003
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Independent Company
Contact Cellerant Therapeutics
Organization Website
Social Links
Contact Email
info@cellerant.com
Phone Number
650-232-2122
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2008 | Public Company | 100 - 250 | 66.4M | $290.6M | |
| 2010 | Privately Held | 25 - 100 | 7.1M | $158M | |
| 2008 | Public Company | 250 - 500 | 3.6M | $358.7M | |
| 2015 | Public Company | 25 - 100 | < 1M | $377M | |
| 2004 | Public Company | 25 - 100 | 123.3M | $98M | |
| 1979 | Public Company | 250 - 500 | 6.5M | $296.4M | |
| 2016 | Public Company | 25 - 100 | < 1M | $169.2M | |
| 2007 | Privately Held | 25 - 100 | < 1M | $162.3M | |
| 1993 | Public Company | 1.0K - 5.0K | 50.2M | $526.4M | |
| 2011 | Privately Held | 25 - 100 | 9.8M | $7.3M | |
| 2009 | Privately Held | 25 - 100 | 5.6M | $197.7M | |
| 2011 | Public Company | 100 - 250 | 156.7M | $808.7M | |
| 2013 | Public Company | 1.0K - 5.0K | 106M | $1.5B | |
| 2013 | Public Company | 100 - 250 | 89.2M | $204.8M | |
| 2009 | Public Company | 1.0K - 5.0K | 45M | $634.9M | |
| 1996 | Public Company | 100K - 9.9M | 50.4B | $0 | |
| 1994 | Public Company | 200-500 | - | $- | |
| 2010 | - | - | $- | ||
| 1999 | - | 100-200 | - | $- | |
| - | - | 10-50 | - | $- |
Employees Turnover 2 quarter 2025
Length of Employment
Employee tenure at Cellerant Therapeutics shows a diverse range of experience levels:
4% for 3–4 years8% for 5–7 years23% for 8–10 years65% have over 11 years of service at Cellerant TherapeuticsContact top employees from
Cellerant Therapeutics
Oscar Jimenez
Facilities Manager
Myralee Martinez
STAFF ACCOUNTANT
Timothy Fong
VP Research
Mark Buttery
Lab Assistant
madhavi mishra
Research Associate
Trang Nguyen
Accounting Manager
Robby Hogle
Member Board Of Directors
Sean Healy
VP of Quality
Ashley Hinkel
Senior Research Associate II
Shailaja Police
Associate
Rod Van Syoc
Sr. Director, Clinical Operations
Isaac Oreoluwa
Clinical Data Manager
inaku paul simon
Strategic Business Development Partnership
Myralee Martinez
Staff Accountant
Lane Welton
Director of Manufacturing
Elisa Brunette
Director
Cellerant Admin
Information Technology Manager
Julie Christensen
Group Leader Cell Biology
helen gebremicael
Senior Development Associate 1
Similar Companies
FAQ
Cellerant Therapeutics operates in the Biotechnology industries. More details can be found on the official website: cellerant.com.
The headquarters of Cellerant Therapeutics are located in , United States.
The current CEO of Cellerant Therapeutics is Ram Mandalam
You can contact Cellerant Therapeutics by phone at 650-232-2122.
Cellerant Therapeutics currently employs 100-200 people.
You can contact Cellerant Therapeutics by phone at 650-232-2122, by email at info@cellerant.com, through social media (LinkedIn), or via the contact form on cellerant.com.
Cellerant Therapeutics's revenue is approximately 8.5M.
Well-known competitors of Cellerant Therapeutics include CytomX Therapeutics, Apexigen, Adaptimmune and Nkarta, Inc..
